Top Markets
Coin of the day
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited

4157
Rang in aandelen #18445
TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm... TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Aandeelprijs
$0.27824149
Marktkapitalisatie
$198.06M
Verandering (1 dag)
-1.24%
Verandering (1 jaar)
-11.01%
Land
TW
Handel TaiGen Biopharmaceuticals Holdings Limited (4157)

Categorie

Aandelsplitsingen voor TaiGen Biopharmaceuticals Holdings Limited (4157)
Het aandeel TaiGen Biopharmaceuticals Holdings Limited (symbool: 4157) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Sep 03, 2026.
Eén aandeel 4157 dat vóór Sep 03, 2026 werd gekocht, staat nu gelijk aan 0 aandelen 4157.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH